2025. Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study. International Journal of Public Research in Medicine and Health. 1, 1 (Sep. 2025), 10–19. DOI:https://doi.org/10.66328/ijprmh.2025.010103.